Inhalational anthrax
Information
- Disease name
- Inhalational anthrax
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01929226 | Completed | Phase 1 | Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers | July 9, 2013 | November 29, 2013 |
| NCT01932242 | Completed | Phase 1 | Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers | July 23, 2013 | April 19, 2014 |
| NCT01932437 | Completed | Phase 1 | Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers | July 26, 2013 | July 3, 2014 |
| NCT01952444 | Completed | Phase 1 | Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers | October 29, 2013 | April 9, 2014 |
| NCT03569553 | Not yet recruiting | A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients | February 11, 2025 | July 2026 |
- OrphaNumber from OrphaNet (Orphanet)
- 247257
- MedGen concept unique identifier (MedGen Concept name)
- C0155866
- MedGen unique identifier (MedGen Concept name)
- 57841